Valuation Actuate Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX 17:34:06 26/08/2026 +04			5-day change	1st Jan Change
1.700 ^USD	+7.59%		+50.48%	-74.18%

08-15	Actuate Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-30	Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 2000 Dynamic Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2024	2025	2026	2027	2028
Market Cap ¹	155.5	142.2	37.94	-	-
Change	-	-8.5%	-73.33%	-	-
Enterprise Value (EV)	155.5	142.2	37.94	37.94	37.94
Change	-	-8.5%	-73.33%	0%	0%
P/E	-	-	-	-	-
PBR	-	-	-	-	-
PEG	-	-	-	-	-
Capitalization / Revenue	-	-	-	-	-
EV / Revenue	-	-	-	-	-
EV / EBITDA	-	-	-	-	-
EV / EBIT	-0x	-0x	-1.75x	-1.43x	-1.22x
EV / FCF	-	-0x	-1.81x	-1.33x	-1.09x
FCF Yield	-	-15.6%	-55.3%	-75.2%	-91.7%
Dividend per Share ²	-	-	-	-	-
Rate of return	-	-	-	-	-
EPS ²	-	-	-	-	-
Distribution rate	-	-	-	-	-
Net sales ¹	-	-	-	-	-
EBITDA	-	-	-	-	-
EBIT ¹	-25.16	-22.5	-21.69	-26.6	-31.04
Net income	-	-	-	-	-
Net Debt	-	-	-	-	-
Reference price ²	7.960	6.120	1.580	1.580	1.580
Nbr of stocks (in thousands)	19,532	23,243	24,014	-	-
Announcement Date	13/03/25	26/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ACTUATE THERAPEUTICS, INC.	-	-	-	-	37.94M
WUXI APPTEC CO., LTD.	21.2x	7.45x	15.19x	1.39%	71.35B
ARGENX SE	36.62x	9.48x	29.1x	0.04%	64.17B
BIONTECH SE	-17.35x	7.3x	-9.17x	-.--%	28.65B
INSMED INCORPORATED	-78.31x	14.63x	-70.55x	-.--%	27.06B
WUXI BIOLOGICS (CAYMAN) INC.	33.85x	6.73x	18.5x	-.--%	27.33B
GENMAB A/S	27.77x	5.2x	17.44x	-.--%	20.47B
PHARMAESSENTIA CORPORATION	56.2x	20.86x	42.32x	0.27%	19.36B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1702.44x	40.01x	873.59x	-.--%	15.96B
EXELIXIS, INC.	17.54x	5.22x	12.17x	-.--%	14.05B
Average	200.00x	12.99x	103.18x	0.19%	28.84B
Weighted average by Cap.	108.36x	10.93x	57.48x	0.37%